Elanix Biotechnologies AG

DB:ELN Stock Report

Market Cap: €428.3k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Elanix Biotechnologies Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lee-Ann Laurent-Applegate

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.5yrs

Recent management updates

No updates

Recent updates


CEO

Lee-Ann Laurent-Applegate

no data

Tenure

Prof. Lee-Ann Laurent-Applegate serves as Chief Executive Officer of Elanix Biotechnologies AG.


Board Members

NamePositionTenureCompensationOwnership
Anja Silling
Chairman of Supervisory Board4.3yrsno datano data
Marco Christen
Vice Chairman of Supervisory Board3.5yrsno data21.4%
€ 91.6k
Yves Bonnard
Member of Supervisory Board3.5yrsno datano data

3.5yrs

Average Tenure

Experienced Board: ELN's board of directors are considered experienced (3.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.